George Chakhava

Effects of Intravenous Eptinezumab vs Placebo on Headache Pain and Most Bothersome Symptom When Initiated During a Migraine Attack

Paul Winner, Peter McAllister, George Chakhava et al. · JAMA · 2021 · 96 citations · Full text

Eptinezumab for the Prevention of Episodic Migraine: Sustained Effect Through 1 Year of Treatment in the PROMISE-1 Study

Timothy R. Smith, Marina Janelidze, George Chakhava et al. · Clinical Therapeutics · 2020 · 53 citations · Full text

Primary Results of PROMISE-1 (Prevention Of Migraine via Intravenous eptinezumab Safety and Efficacy–1) Trial: a Phase 3, Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Eptinezumab for Prevention of Frequent Episodic Migraines (S20.001)

Joel R. Saper, Richard B. Lipton, David Kudrow et al. · Neurology · 2018 · 27 citations

Cluster Headache, Frequent Episodic Migraine, Primary Results +10

Rapid resolution of migraine symptoms after initiating the preventive treatment eptinezumab during a migraine attack: results from the randomized RELIEF trial

Jessica Ailani, Peter McAllister, Paul Winner et al. · BMC Neurology · 2022 · 20 citations · Full text

Eptinezumab treatment initiated during a migraine attack is associated with meaningful improvement in patient-reported outcome measures: secondary results from the randomized controlled RELIEF study

Peter McAllister, Paul Winner, Jessica Ailani et al. · The Journal of Headache and Pain · 2022 · 11 citations · Full text